Compare EMBJ & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | TECH |
|---|---|---|
| Founded | 1969 | 1976 |
| Country | Brazil | United States |
| Employees | 20744 | N/A |
| Industry | Aerospace | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.6B |
| IPO Year | N/A | 1995 |
| Metric | EMBJ | TECH |
|---|---|---|
| Price | $62.79 | $55.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $84.00 | $71.82 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | 0.35% | ★ 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | N/A | $2.49 |
| Revenue Next Year | $13.60 | $6.40 |
| P/E Ratio | $159.30 | ★ $113.32 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $54.28 | $46.05 |
| 52 Week High | $80.75 | $72.16 |
| Indicator | EMBJ | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 48.68 |
| Support Level | $60.76 | $49.55 |
| Resistance Level | $65.81 | $58.88 |
| Average True Range (ATR) | 2.03 | 2.71 |
| MACD | -0.48 | -0.35 |
| Stochastic Oscillator | 18.06 | 33.57 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.